|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2827 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/2896 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K2039/505 | (2013.01) |
| (11) | Number of the document | 3433273 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17713672.8 |
| Date of filing the European patent application | 2017-03-27 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/057220 |
| Date | 2017-03-27 |
| (87) | Number | WO 2017/162890 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 16305350 | 2016-03-25 | EP |
| (72) |
ZHUKOVSKY, Eugene , FR
LEGER, Olivier , FR
MORSE, Richard J. , FR
|
| (73) |
Biomunex Pharmaceuticals ,
113 rue de la Tour, 75116 Paris,
FR
|
| (54) | BINDING MOLECULES TO CD38 AND PD-L1 |
| BINDING MOLECULES TO CD38 AND PD-L1 |